www.mhlw.go.jp/stf/newpage_18199.html
archives
This URL has 1 public saves. The first save was Apr 8, 2026, 06:02 PM and the latest save was Apr 8, 2026, 06:02 PM.
View recent saves on this domain
Latest saved version
医薬品医療機器等法に基づく新型コロナウイルス感染症に係る治療薬の承認について｜厚生労働省
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.mhlw.go.jp/stf/newpage_18199.html
About this page
This page is a press release from Japan's Ministry of Health, Labour and Welfare dated April 23, 2021, announcing the approval of Olumiant tablets as a COVID-19 treatment. The active ingredient is baricitinib, a JAK inhibitor. It is approved for pneumonia patients requiring oxygen therapy, administered orally at 4mg once daily in combination with remdesivir. The application was filed by Eli Lilly Japan K.K. on December 25, 2020.
Saved versions
www.mhlw.go.jp/stf/newpage_18199.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.